Entinostat plus exemestane for hormone receptor-positive advanced breast cancer: long-term overall survival results from the EOC103A3101 randomized controlled trial
Jiani Wang, Qingyuan Zhang, Xichun Hu, Tao Sun, Wei Li, Quchang Ouyang, Jingfen Wang, Zhongsheng Tong, Min Yan, Huiping Li, Xiaohua Zeng, Changping Shan, Xian Wang, Jian Zhang, Yue Zhang, Liang Zhang, Hongyan Shang, Binghe Xu · 2026
Read Entinostat plus exemestane for hormone receptor-positive advanced breast cancer: long-term overall survival results from the EOC103A3101 randomized controlled trial by Jiani Wang, Qingyuan Zhang, Xichun Hu, Tao Sun, Wei Li, Quchang Ouyang, Jingfen Wang, Zhongsheng Tong, Min Yan, Huiping Li, Xiaohua Zeng, Changping Shan, Xian Wang, Jian Zhang, Yue Zhang, Liang Zhang, Hongyan Shang, Binghe Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13680365.txt.
Description
Jiani Wang and a large Chinese team reported long-term survival from a trial adding a gene-switch drug to hormone therapy in breast cancer in a 2026 paper. The cancer feeds on hormones but not a second growth signal, and it had returned after hormone treatment. In all, 354 patients were split two-to-one between the added drug and a placebo.
After about thirty-two months of follow-up, median survival was near thirty-nine months with the added drug against twenty-nine without. The gap did not reach firm statistical ground on its own, though adjusted reads looked stronger. Time before chemotherapy was nearly doubled in the drug arm. Heavy side effects hit about two thirds of that arm, with no new safety surprises. The authors read the trend as a real gain.
Catalog record
| CREATOR | Jiani Wang, Qingyuan Zhang, Xichun Hu, Tao Sun, Wei Li, Quchang Ouyang, Jingfen Wang, Zhongsheng Tong, Min Yan, Huiping Li, Xiaohua Zeng, Changping Shan, Xian Wang, Jian Zhang, Yue Zhang, Liang Zhang, Hongyan Shang, Binghe Xu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |